Transfusion-related adverse events at the tertiary care center in North India: An institutional hemovigilance effort

Asian Journal of Transfusion Science

Volumn 5, Issue 2, 2011, Pages 164-170

  Bhattacharya, Prasun ^a   Marwaha, Neelam ^b   Dhawan, Hari Krishan ^b   Roy, Pallab ^b   Sharma, R R ^b  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

adverse events of transfusion; haemolytic transfusion reaction; Hemovigilance; risk associated with transfusion; transfusion reaction

Indexed keywords

EID: 84863007226     PISSN: 09736247     EISSN: 19983565     Source Type: Journal    
DOI: 10.4103/0973-6247.83245     Document Type: Article

References (17)

1. Aubuchnon JP, Kruskall MS. Transfusion safety: Realigning eff orts with risks. Transfusion 1997;37:1211-6.
2. Mazzei CA, Popovsky MA, Kopko PM. Noninfectious complications of blood transfusion. In: Roback JD, Combs MR, Grossman BJ, Hillyer CD, eds. Technical manual. 16th ed. Maryland: American Association of Blood Banks, 2008: 715-51.
3. Moore S, Taswell HF, Pineda AA. Delayed hemolytic transfusion reactions: Evidence of the need for an improved pretransfusion compatibility test. Am J Clin Path 1980;74:94-7. (Pubitemid 10027461)
4. Lichtiger B, Thornton E. Hemolytic transfusion reactions in oncology patients: Experience in a large cancer center. J Clin Oncol 1984;2:438-42. (Pubitemid 14075974)
5. Robillard P, Karl Itaj N. Incidence of adverse transfusion reactions in the Quebec Hemovigilance System. Vox Sang 2002;83:120 (abstr suppl).
6. Heddle NM, Blajchman MA, Meyer RM, Lipton JH, Walker IR, Sher GD, et al. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion 2002;42:556-66.
7. NIH consensus conference: Perioperative red cell transfusion. JAMA 1988;260:2700-3.
8. Heddle NM, Klama LN, Griffi th L, Roberts R, Shukla G, Kelton JG. A prospective study to identify risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 1993;33:794-7. (Pubitemid 23332497)
9. Ulhman EJ, Isgrigs E, Wallhermanfechtel M, Goodnough LT. Prestorage universal WBC reduction of RBC units does not aff ect the incidence of transfusion reactions. Transfusion 2001;41: 997-1000. (Pubitemid 33642788)
10. Kleinman S, Chan P, Robillard P. Risk associated with transfusion of cellular blood component in Canada. Transfus Med Rev 2003;17:120-62. (Pubitemid 36539254)
11. Tanz WS, King KE, Ness PM. Re-evaluation of transfusion reaction rates associated with leukocyte-reduced red blood cells. Transfusion 2001;41:7s (abstr suppl).
12. Domen RE, Heoltage GA, Allergic transfusion reactions. Arch Path Lab Med 2003;127:316-20.
13. Sazarma K. Bacteria in blood for transfusion: A review. Arch Path Lab Med 1994;118:350-65.
14. Kuehner MJ, Roth VR, Haley NR. Transfusion-transmitt ed bacterial infection in the United States, 1998 through 2000. Transfusion 2001;41 :1493-9. (Pubitemid 34072672)
15. Popovsky MA, Taswell RF. Circulatory overload: An underdiagnosed consequence of transfusion. Vox Sang 2002;83:469 (abstr suppl).
16. Kathryn E, Webert, Blajchman MA. Transfusion-related acute lung injury. Transfus Med Rev 2003;17:252-62.
17. Sharma RR, Bhatt acharya P, Thakral B, Saluja K, Marwaha N. Transfusion related acute lung injury. Indian J Pathol Microbiol 2009;52:561-3.